Consider Ethical Questions of 'Designer Babies'
By Elizabeth M. Meade,
The Morning Call
| 03. 10. 2014
A recent
New York Times article (Feb. 25) on a new fertility procedure that involves using the genetic material of three people to create a baby does a very good job of outlining the major ethical challenges posed by the technique.
The procedure is intended to produce children free of certain genetic defects, by replacing the mitochondria of the egg with the mitochondria of a donor who is free of the genetic defect. It could potentially be a godsend to families who risk passing certain catastrophic genetic defects on to their children. But, as The Times article rightly points out, it raises the ethical questions of whether we should be designing our children to be free of whatever we consider to be defects.
"Designer babies," as they are often called, represent both the best and worst of our understanding of parenthood. Several techniques already allow us to prevent passing genetic defects on to the next generation.
For years, fertility clinics have been able to screen embryos for genetic defects before implanting them; in some cases, halting or slowing the prevalence...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...